Michela Guardascione

6PUBLICATIONS
20CO-AUTHORS
Gene and molecular therapyPharmaceutical delivery technologiesImmunogenetics (incl. genetic immunology)Predictive and prognostic markersCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Nov 13, 2023
Therapeutic drug monitoring and pharmacogenetics to tune imatinib exposure in gastrointestinal stromal tumor patients: hurdles and perspectives for clinical implementation.

Sara Gagno, Chiara Dalle Fratte, Bianca Posocco

|Jun 15, 2023
The use of therapeutic drug monitoring to highlight an over-looked drug-drug interaction leading to imatinib treatment failure.

Sara Gagno, Angela Buonadonna, Chiara Dalle Fratte

|Feb 25, 2023
Impact of ABCG2 and ABCB1 Polymorphisms on Imatinib Plasmatic Exposure: An Original Work and Meta-Analysis.

Chiara Dalle Fratte, Jerry Polesel, Sara Gagno

|Sep 30, 2022
CYP2D6 and CYP2C8 pharmacogenetics and pharmacological interactions to predict imatinib plasmatic exposure in GIST patients.

Chiara Dalle Fratte, Sara Gagno, Rossana Roncato

|Aug 27, 2021
NAFLD-Related Hepatocarcinoma: The Malignant Side of Metabolic Syndrome.

Anna Michelotti, Marco de Scordilli, Lorenza Palmero

|Sep 04, 2020
Immune Checkpoint Inhibitors as Monotherapy or Within a Combinatorial Strategy in Advanced Hepatocellular Carcinoma.

Michela Guardascione, Giuseppe Toffoli

Pageof 1

Frequent Collaborators

5 joint publications

Giuseppe Toffoli

4 joint publications

Erika Cecchin

4 joint publications

Rossana Roncato

4 joint publications

Chiara Dalle Fratte